Table 2 Baseline comorbidities

From: Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

 

N

%

Total patients

40

100

N comorbidity

 0

12

 

 1

10

 

 2

8

 

 >2

10

 

Type

 Cardiovascular

39

 

 Respiratory

8

 

 Neurologic

2

 

 Diabetes

3

 

 Urinary

5

 

Creatinine level

 Median value (mg dl−1)

1.04

 

 Range (mg dl−1)

0.59–2.72

 

 <1.2 mg dl−1

23

 

 >1.2 mg dl−1

10

 

 Not available

7

 
Back to article page